Cleared Traditional

K850486 - GENERAL DIAG. CHROMOSTRATE HEPARIN ASSAY
(FDA 510(k) Clearance)

K850486 · Warner-Lambert Co. · Hematology
May 1985
Decision
90d
Days
Class 2
Risk

K850486 is an FDA 510(k) clearance for the GENERAL DIAG. CHROMOSTRATE HEPARIN ASSAY, a Assay, Heparin (Class II — Special Controls, product code KFF), submitted by Warner-Lambert Co. (Morris Plains, US). The FDA issued a Cleared decision on May 8, 1985, 90 days after receiving the submission on February 7, 1985. This device falls under the Hematology review panel. Regulated under 21 CFR 864.7525.

Submission Details

510(k) Number K850486 FDA.gov
FDA Decision Cleared SESE
Date Received February 07, 1985
Decision Date May 08, 1985
Days to Decision 90 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary

Device Classification

Product Code KFF — Assay, Heparin
Device Class Class II — Special Controls
CFR Regulation 21 CFR 864.7525

Similar Devices — KFF Assay, Heparin

All 45
HemosIL Liquid Anti-Xa
K213464 · Instrumentation Laboratory CO · Oct 2022
INNOVANCE(r) Heparin Reagents, INNOVANCE(r) Heparin Calibrator, INNOVANCE(r) Heparin UF and Heparin LMW Controls
K162540 · Siemens Healthcare Diagnostics Prodcts GmbH · Aug 2017
STA(R) - LIQUID ANTI-XA, MULTI HEP CALIBRATOR, QUALITY HNF / UFH, QUALITY HBPM / LMWH
K111822 · Diagnostica Stago, Inc. · Oct 2011
HEMOSIL LIQUID HEPARIN, HEPARIN CALIBRATORS AND LMW AND UF HEPARIN CONTROLS
K090209 · Instrumentation Laboratory CO · Jun 2009
BIOPHEN HEPARIN 3, BIOPHEN HEPARIN 6
K050367 · Hyphen Biomed · May 2006
ENOXAPARIN TEST CARD
K013305 · Cardiovascular Diagnostics, Inc. · Aug 2002